Surgical treatment of acute cholecystitis in patients with confirmed COVID-19: Ten case reports and review of literature

Table 1 Demographic information of confirmed coronavirus disease 2019 patients with acute cholecystitis (n = 10) (mean ± SD)

Classification	n = 10
Sex, n (%)
Female	4
Male	6
Age (yr), mean (range)	47.1 (20-74)
BMI (kg/m2), mean (range)	28.4 (20-43)
Current Smokers, n (%)	3
ASA classification, n (%)
I	2
II	4
III	4
Comorbidities, n (%)
Diabetes	2
Hypertension	4
CRD	2
Lupus	1
No	6
Preoperative qSOFA score, n (%)
Not high risk (0-1)	4
High risk (> 2)	6
COVID-19 symtoms
Yes	6
No	4
Preoperative studies
Hemoglobin (g/dL)	12.8 (2.8)
Platelets (n × 103/μL)	284 (128.7)
Leucocytes (n/μL)	11.95 (5.6)
CRP (mg/dL)	20.1 (12.5)
Total Bilirubin (mg/dL)	1.29 (1.7)
Gamma-glutamyl transferase (IU/L)	163.1 (198.1)
Alanine aminotransferase (IU/L)	86.1 (102.8)
Aspartate aminotransferase (IU/L)	59.9 (46.7)
Alkaline fosfatase (IU/L)	199 (189.7)
LDH (IU/L)	215.1 (63.3)
Albumin (g/dL)	4.17 (0.4)
Ferritin (ng/mL)	565 (304.5)
Creatinine (md/dL)	1.02 (0.5)

BMI: Body mass index; CRD: Chronic renal disease; qSOFA: Quick Sequential Organ Failure Assessment; CRP: C-reactive protein.